SCHEMBL701941

SCHEMBL701941

Cc1ccc(C(=O)O)nc1C

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.60
L3MBTL1 Q9Y468 3/20 0.60
TDP1 Q9NUW8 2/20 0.50
ALOX15 P16050 1/20 0.50
TSHR P16473 1/20 0.50
ACMSD Q8TDX5 1/20 0.50
MAPT P10636 1/20 0.49
RAB9A P51151 1/20 0.49
MGAM O43451 1/20 0.45
P4HTM Q9NXG6 2/20 0.43
P4HA1 P13674 1/20 0.43
MIF P14174 1/20 0.43
NOS3 P29474 1/20 0.43
NOS1 P29475 1/20 0.43
NOS2 P35228 1/20 0.43
ALDH1A1 P00352 1/20 0.42
SORT1 Q99523 3/20 0.41
LMNA P02545 3/20 0.41
KMT2A Q03164 2/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3580429 0.82 NOS3 (0.43) KDM4EL3MBTL1TDP1MAPTRAB9A
SCHEMBL14919050 0.80 KDM4E (0.58) KDM4EL3MBTL1TDP1ALOX15TSHR
SCHEMBL26908103 0.80 KDM4E (0.51) KDM4EL3MBTL1TDP1ALOX15TSHR
SCHEMBL19857471 0.80 KDM4E (0.48) KDM4EL3MBTL1TDP1ALOX15TSHR
SCHEMBL12707195 0.80 NOS3 (0.41) KDM4EL3MBTL1TDP1MAPTRAB9A
SCHEMBL23530075 0.80 GABRP (0.62) KDM4EL3MBTL1TDP1ALOX15TSHR
SCHEMBL3999989 0.80 NOS3 (0.46) KDM4EL3MBTL1TDP1NOS3NOS1
Hydrochloric Acid SCHEMBL1022194 0.78 NOS3 (0.40) KDM4EL3MBTL1TDP1MAPTRAB9A
SCHEMBL1425108 0.78 KDM4E (0.56) KDM4EL3MBTL1TDP1ALOX15TSHR
SCHEMBL1106060 0.78 KDM4E (0.47) KDM4EL3MBTL1TDP1ALOX15TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220326230-A1 NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF FIRMENICH INCORPORATED (US) 2022-10-13 US disclosed
US-20220089592-A1 IMIDAZO[1,2-A]PYRIDINYL DERIVATIVES AS IRAK4 INHIBITORS BIOGEN MA INC. 2022-03-24 US disclosed
US-11268952-B2 Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof FIRMENICH INCORPORATED (US) 2022-03-08 US disclosed
EP-3911652-A1 IMIDAZO[1,2-A]PYRIDINYL DERIVATIVES AS IRAK4 INHIBITORS Biogen MA Inc. (US) 2021-11-24 EP disclosed
WO-2020150626-A1 IMIDAZO[1,2-A]PYRIDINYL DERIVATIVES AS IRAK4 INHIBITORS BIOGEN MA INC. (US) 2020-07-23 WO disclosed
US-20200225217-A1 NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF FIRMENICH INCORPORATED (US) 2020-07-16 US disclosed
US-10557845-B2 Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof FIRMENICH INCORPORATED (US) 2020-02-11 US disclosed
EP-1659881-B1 NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF SENOMYX INC (US) 2019-04-03 EP disclosed
EP-3431464-A2 NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF Senomyx Inc. (US) 2019-01-23 EP disclosed
US-20180364220-A1 NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF FIRMENICH INCORPORATED 2018-12-20 US disclosed
WO-2003031621-A2 A HUMAN G PROTEIN COUPLED RECEPTOR AMERSHAM PLC (GB) 2003-04-17 WO disclosed
WO-1997036902-A1 TRANS-2,6-, 3,6- AND 4,6-DIAZA-5,6,6a,7,8,12b-HEXAHYDROBENZO[C]PHENANTHRENE COMPOUNDS AS DOPAMINE AGONISTS ABBOTT LABORATORIES (US) 1997-10-09 WO disclosed
US-5668141-A TREATMENT OF PSYCHOLOGICAL, NEUROLOGICAL AND CARDIOVASCULAR DISORDERS ABBOTT LABORATORIES (US) 1997-09-16 US disclosed
EP-0663822-A4 METHODS AND COMPOSITIONS FOR TREATING HYPERTENSION, ANGINA AND OTHER DISORDERS USING OPTICALLY PURE S(-) NITRENDIPINE. SEPRACOR INC (US) 1997-04-23 EP disclosed
EP-0663822-A1 METHODS AND COMPOSITIONS FOR TREATING HYPERTENSION, ANGINA AND OTHER DISORDERS USING OPTICALLY PURE S(-) NITRENDIPINE SEPRACOR, INC. (US) 1995-07-26 EP disclosed
WO-1994007476-A1 METHODS AND COMPOSITIONS FOR TREATING HYPERTENSION, ANGINA AND OTHER DISORDERS USING OPTICALLY PURE S(-) NITRENDIPINE SEPRACOR, INC. (US) 1994-04-14 WO disclosed
CN-86107899-A The novel basic substituted pyridine compound, preparation method, contained drug and application thereof 1987-07-29 CN disclosed
EP-0053789-B1 2-PYRIDINECARBOXAMIDE DERIVATIVE, PROCESS FOR PREPARING SAME AND PHARMACEUTICAL COMPOSITION, USEFUL AS AN ANTI-ALLERGIC AGENT Tanabe Seiyaku Co., Ltd. (JP) 1985-03-27 EP disclosed
US-4404214-A 2-Pyridinecarboxamide derivatives compositions containing same and method of using same TANABE SEIYAKU CO., LTD. (JP) 1983-09-13 US disclosed
EP-0053789-A1 2-Pyridinecarboxamide derivative, process for preparing same and pharmaceutical composition, useful as an anti-allergic agent Tanabe Seiyaku Co., Ltd. (JP) 1982-06-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200225217-A1 NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF TAS1R2, TAS1R1, TAS2R40 KDM4E 2861/4885L3MBTL1 4093/4885TDP1 4029/4885
US-10557845-B2 Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof TAS1R2, TAS1R1, TAS2R40 KDM4E 2551/4885L3MBTL1 3768/4885TDP1 3961/4885
US-20180364220-A1 NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF TAS1R2, TAS1R1, TAS2R30 KDM4E 2873/4885L3MBTL1 4091/4885TDP1 3974/4885
US-20220326230-A1 NOVEL FLAVORS, FLAVOR MODIFIERS, TASTANTS, TASTE ENHANCERS, UMAMI OR SWEET TASTANTS, AND/OR ENHANCERS AND USE THEREOF TAS1R2, TAS1R1, TAS2R30 KDM4E 2873/4885L3MBTL1 4091/4885TDP1 3974/4885
US-11268952-B2 Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof TAS2R40, TAS1R2, TAS1R1 KDM4E 2679/4885L3MBTL1 3984/4885TDP1 3965/4885
US-20220089592-A1 IMIDAZO[1,2-A]PYRIDINYL DERIVATIVES AS IRAK4 INHIBITORS IRAK4, IRAK2, IRAK1 KDM4E 104/4885L3MBTL1 1471/4885TDP1 796/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.